ArticleLung2012

Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.

WeiYing Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.